查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1462768

無針注射系統市場至2030年的預測：按產品、類型、技術、可用性、施用部位、應用、最終用戶和地區的全球分析

Needle-Free Injection System Market Forecasts to 2030 - Global Analysis By Product, Type, Technology, Usability, Site of Delivery, Application, End User and by Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的資料，2023年全球無針注射系統市場規模為 1.756 億美元，預計預測期內年複合成長率為 19%，到2030年將達到 5.934 億美元。

無針注射系統為傳統注射提供了一個方便、無痛的替代方案。這項突破性技術利用高壓迫使稀薄的液體溶液穿過皮膚，無需使用針頭。此外，無針注射系統加快了醫療程序，同時透過精確劑量提高患者舒適度和依從性，並降低針頭相關傷害和感染疾病的風險。

根據美國醫學協會的說法，無針輸液系統等醫療技術的進步對於透過提供創新的、侵入性較小的給藥方法來改善患者護理非常重要。

無痛給藥技術的需求

由於包括患者偏好在內的多種因素，無痛給藥方法的需求量很大。對於老年和兒童患者尤其如此，他們可能會覺得傳統的針頭注射不舒服或有更大的焦慮。對疼痛的厭惡和對針頭的恐懼症也增加了患者尋求替代給藥方法的可能性。此外，無針注射系統的技術發展進一步刺激了對這些系統的需求，這些系統可確保無痛給藥、提供精確的劑量控制、減少藥物浪費的可能性並改善治療效果。

成本和價格問題

無針輸液系統可能會產生巨大的初始成本，包括購買耗材、培訓醫務人員以及與目前的醫療保健設定整合。由於持續的維護、校準和消耗品成本，這些系統可能會給醫療機構帶來財務挑戰。此外，不同醫療保健系統之間的無針輸液系統的覆蓋範圍和償付指南可能存在差異，這可能會影響患者的使用和負擔能力。

擴大醫療應用

無針注射系統有很多機會將其治療應用擴展到各種醫學專業。人們對使用該技術提供生技藥品、胜肽和創新治療方法的興趣成長，超越了胰島素輸送和疫苗接種等傳統使用案例。配方科學、藥物傳輸工程和微流體的進步使無針注射系統能夠處理更廣泛的藥物，包括敏感的生物製藥和高黏度配方。此外，治療應用的普及不僅滿足了未滿足的臨床需求，而且擴大了患者獲得最先進治療的機會，並為製造商創造了新的市場和收益來源。

市場飽和度與競爭格局

無針注射器市場的特點是競爭激烈，長期競爭對手和新進業者都在爭奪市場佔有率。隨著技術的發展和廣泛使用，市場可能會飽和狀態，這可能會導致定價壓力、商品化和報酬率下降。由於現有製造商相對於小型公司的競爭優勢，例如廣泛的研發能力和全球分銷網路，新參與企業可能會發現很難進入市場。此外，替代藥物傳遞技術（例如經皮吸收貼片、微針貼片和口服輸送系統）的發展損害無針注射系統的優勢。

COVID-19 的影響：

無針注射系統市場受到了 COVID-19 大流行的多方面影響。無針注射系統變得越來越受歡迎，因為它們提供了無針選項，可以降低針刺傷害和交叉污染的風險。一方面，人們對感染控制和最大限度地降低與醫療保健相關的感染相關的風險越來越感興趣。疫情遠端醫療凸顯了對患者自我管理設備（例如無針注射系統）用於家庭治療計劃和虛擬就診的需求。然而，供應鏈中斷、經濟不確定性以及集中資源應對 COVID-19 的決定導致選擇性治療和非必要醫療程序的延誤。

彈簧細分市場預計將成為預測期內最大的細分市場

採用彈簧技術的無針注射系統佔據最大的市場佔有率。以彈簧為基礎的系統不需要針頭，利用壓縮彈簧產生的機械力通過皮膚輸送藥物。這些系統因其價格實惠、可靠且易於使用而廣泛使用。精確的劑量控制、易於使用以及交叉污染和針刺傷害的低風險使其適合各種醫療應用，包括疫苗接種、胰島素給藥和荷爾蒙療法。此外，彈簧加載的無針注射系統易於使用，適合患者在家中和診所自行給藥。

預計腫瘤學在預測期內將經歷最高的年複合成長率。

腫瘤學領域預計將在無針注射系統市場中擁有最高的年複合成長率。在腫瘤學領域，無針注射系統用於實施各種癌症治療，包括免疫療法、標靶治療和化療藥物。此外，推動該成長的主要因素是全球癌症發病率上升、對患者友善且高效的藥物輸送系統的需求以及改進的癌症治療選擇。對於癌症患者來說，無針注射系統具有許多好處，包括減輕疼痛、更佳堅持治療以及提高藥物傳遞的精確度。

比例最高的地區：

北美佔據無針注射器市場的最大佔有率。這一優勢得益於發達的醫療基礎設施、高昂的醫療支出、完善的法規環境以及較早採用尖端醫療技術。此外，研發支出的增加、糖尿病和癌症等慢性病盛行率的增加以及公眾對感染控制程序和針刺傷的認知的提高也推動了市場的成長。此外，無針注射系統在北美臨床應用中的廣泛使用歸因於主要行業參與者的策略行動、製藥和設備製造商之間的聯盟以及有利的償付政策。

年複合成長率最高的地區：

對於無針注射器市場，亞太地區預計將以最高的年複合成長率成長。造成這種成長的因素有很多，包括醫療保健成本上升、醫療保健服務範圍擴大、尖端醫療技術的使用增加以及公眾對無針注射系統好處的認知提高。此外，由於人口眾多，尤其是中國和印度，該地區的無針注射系統製造商有許多市場機會。此外，由於醫療保健基礎設施的改善、監管變化以及研發支出等努力，亞太市場不斷成長。

免費客製化服務

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多3家公司）
    • 主要企業SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶興趣對主要國家的市場估計、預測和年複合成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章 執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 研究資訊來源
    • 主要研究資訊來源
    • 二次研究資訊來源
    • 先決條件

第3章 市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 技術分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • COVID-19 的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章 全球無針注射系統市場：依產品

  • 可填充無針注射器
  • 預填充無針注射器
  • 其他產品

第6章 全球無針注射系統市場：依類型

  • 液體無針注射器
  • Projectile/Depot無針注射器
  • 粉末無針注射器
  • 其他類型

第7章 全球無針注射系統市場：依技術分類

  • 彈簧
  • 氣動
  • 雷射
  • 振動
  • 其他技術

第8章 全球無針注射系統市場：按可用性

  • 一次性無針注射器
  • 可重複使用的無針注射器

第9章 全球無針注射系統市場：依管理地點分類

  • 皮下注射器
  • 肌肉注射器
  • 皮內注射器

第10章 全球無針注射系統市場：依應用分類

  • 疫苗遞送
  • 胰島素給藥
  • 腫瘤學
  • 疼痛管理
  • 皮膚科
  • 其他用途

第11章 全球無針注射系統市場：依最終用戶分類

  • 醫院和診所
  • 居家照護環境
  • 研究實驗室
  • 製藥和生物技術公司
  • 其他最終用戶

第12章 全球無針注射系統市場：依地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東、非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第13章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第14章 公司概況

  • Ferring BV
  • INVIO Pharmaceutical Inc
  • Bioject Medical Technologies
  • Medical International Technology, Inc
  • PharmaJet
  • 3M
  • Portal Instruments
  • NovaXS Biotech
  • Enesi Pharma Limited
  • Antares Pharma
  • NuGen Medical Devices
  • Crossject SA
  • Injex Pharma AG
Product Code: SMRC25819

According to Stratistics MRC, the Global Needle-Free Injection System Market is accounted for $175.60 million in 2023 and is expected to reach $593.40 million by 2030 growing at a CAGR of 19% during the forecast period. The administration of medications is revolutionized by a needle-free injection system, which provides a convenient and painless substitute for traditional injections. This ground-breaking technology does away with the need for needles by using high pressure to push a thin stream of medication through the skin. Moreover, needle-free injection systems expedite medical procedures while improving patient comfort and compliance through accurate dosage delivery and a decreased risk of needle-related injuries or infections.

According to the American Medical Association, Advancements in medical technology, such as Needle-Free Injection Systems, are crucial in improving patient care by offering innovative and less invasive methods of medication delivery.

Market Dynamics:

Driver:

Demand for painless medication delivery techniques

Painless drug delivery methods are in demand due to a number of factors, including patient preferences. This is particularly true for older and pediatric populations, who may find traditional needle injections to be uncomfortable or cause them more anxiety. Aversion to pain or needle phobia also increases the likelihood that a patient will look for alternate delivery methods. Furthermore, the need for these systems is being further stimulated by technological developments in needle-free injection systems, which guarantee painless administration and provide accurate dosage control, lowering the possibility of medication waste and improving therapeutic performance.

Restraint:

Cost consequences and issues with affordability

Needle-free injection systems can come with a hefty upfront cost, which includes purchasing supplies, educating medical staff, and integrating the system with the current healthcare setup. These systems may present financial difficulties for healthcare facilities due to their ongoing maintenance, calibration, and consumable costs, especially in resource-constrained environments or areas with tight healthcare budgets. Additionally, there may be differences in the coverage and reimbursement guidelines for needle-free injection systems among various healthcare systems, which could affect patients' access to and affordability.

Opportunity:

Extension of medicinal uses

There are a lot of opportunities for expanding therapeutic applications across different medical specialties with needle-free injection systems. Interest in using this technology to administer biologics, peptides, and innovative treatments is growing beyond traditional use cases like insulin delivery and vaccinations. Advances in formulation science, drug delivery engineering, and microfluidics have made it possible for needle-free injection systems to handle a wider variety of drugs, including sensitive biopharmaceuticals and high-viscosity formulations. Moreover, the proliferation of therapeutic applications not only fills unmet clinical needs but also expands patient access to cutting-edge treatments and creates new markets and revenue streams for manufacturers.

Threat:

Market saturation and competitive landscape

The market for needle-free injection systems is characterized by fierce competition between long-standing competitors and recent entries vying for market share. The market may get more saturated as the technology develops and becomes more widely used, which could result in price pressure, commoditization, and a decline in profit margins. New entrants may find it difficult to break into the market due to established manufacturer's competitive advantage over smaller businesses, which includes extensive R&D capabilities and global distribution networks. Furthermore, the dominance of needle-free injection systems is in jeopardy due to the development of alternative drug delivery technologies like transdermal patches, microneedle patches, and oral delivery systems.

Covid-19 Impact:

The market for needle-free injection systems has seen differing effects from the COVID-19 pandemic. Needle-free injection systems have become more popular because they provide a needle-free option that lowers the risk of needlestick injuries and cross-contamination. On the one hand, this is due to the increased focus on infection control and minimizing risks associated with healthcare-associated transmission. The necessity of patient self-administration devices, such as needle-free injection systems, for at-home treatment plans and virtual consultations has been highlighted by the pandemic's shift towards telemedicine and remote healthcare delivery models. However, delays in elective treatments and non-essential medical procedures have been caused by supply chain disruptions, economic uncertainty, and the decision to focus resources on COVID-19 response efforts.

The Spring-based segment is expected to be the largest during the forecast period

The needle-free injection system with spring technology commands the largest market share. Without the need for needles, spring-based systems deliver drugs through the skin using the mechanical force produced by a compressed spring. Because of these systems' affordability, dependability, and ease of use, they are extensively used. They are appropriate for a variety of medical applications, such as vaccinations, insulin delivery, and hormone therapy; because they provide accurate dosage control, ease of use, and a low risk of cross-contamination or needlestick injuries. Additionally, spring-based needle-free injection systems are easy to use, which makes them appropriate for patient self-administration in both home and clinical settings.

The Oncology segment is expected to have the highest CAGR during the forecast period

In the market for needle-free injection systems, the oncology segment is anticipated to have the highest CAGR. In the oncology segment, needle-free injection systems are used to administer different cancer therapeutics, such as immunotherapies, targeted therapies, and chemotherapy medications. Moreover, the primary factors driving this growth are the rising global incidence of cancer, the need for more patient-friendly and efficient drug delivery systems, and improvements in cancer treatment options. For cancer patients, needle-free injection systems provide a number of benefits, including decreased pain, better adherence to treatment, and increased accuracy in drug delivery-all of which are critical for maximizing therapeutic results and minimizing side effects.

Region with largest share:

In the market for needle-free injection systems, North America has the largest share. The presence of a well-established healthcare infrastructure, high healthcare spending, a strong regulatory environment, and early adoption of cutting-edge medical technologies are some of the factors that are credited with this dominance. Growth in the market is also fueled by rising spending on R&D, an increase in the prevalence of chronic illnesses like diabetes and cancer, and increased public awareness of infection control procedures and needlestick injuries. Additionally, the extensive use of needle-free injection systems in North America's clinical applications can be attributed to the strategic actions taken by major industry participants, partnerships between drug companies and device manufacturers, and advantageous reimbursement policies.

Region with highest CAGR:

In the market for needle-free injection systems, Asia Pacific is anticipated to grow at the highest CAGR. Numerous factors are contributing to this growth, such as rising healthcare costs, greater access to healthcare services, increased use of cutting-edge medical technologies, and rising public awareness of the advantages of needle-free injection systems. Furthermore, there are a lot of market opportunities for Needle-Free Injection System manufacturers in the region due to the large population base, especially in China and India. The Asia Pacific market is also growing as a result of efforts to improve the infrastructure for healthcare, regulatory changes, and R&D spending.

Key players in the market

Some of the key players in Needle-Free Injection System market include Ferring B.V, INVIO Pharmaceutical Inc, Bioject Medical Technologies, Medical International Technology, Inc, PharmaJet, 3M, Portal Instruments, NovaXS Biotech, Enesi Pharma Limited, Antares Pharma, NuGen Medical Devices, Crossject SA and Injex Pharma AG.

Key Developments:

In January 2024, INOVIO, a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases, announced a clinical collaboration and supply agreement with Coherus BioSciences, Inc. to evaluate the combination of INO-3112 and LOQTORZI(TM) as a potential treatment for patients with locoregionally advanced, high-risk, HPV16/18 positive oropharyngeal squamous cell carcinoma (OPSCC), a type of head and neck cancer commonly known as throat cancer.

In May 2023, 3M is expanding its ongoing commitment to materials science-based climate tech solutions by working with Svante Technologies, Inc. (Svante) to develop material that can trap carbon dioxide (CO2) found in the atmosphere and permanently remove it.

In December 2023, NuGen Medical Devices Inc. a leading developer of needle-free devices to administer therapeutics subcutaneously, is pleased to announce that, as of December 12, 2023, Advance Medical Life Co. Ltd., a limited liability company domiciled in Bangkok, Thailand, became the exclusive distributor for NuGen's needle-free InsuJet(TM) device aimed at improving the delivery of care and life for millions of diabetics worldwide. InsuJet(TM) is approved for sale in Thailand as a medical device.

Products Covered:

  • Fillable Needle-free Injectors
  • Prefilled Needle-free Injectors
  • Other Products

Types Covered:

  • Liquid-based Needle-free Injectors
  • Projectile/Depot-based Needle-free Injectors
  • Powder-based Needle-free Injectors
  • Other Types

Technologies Covered:

  • Spring-based
  • Gas-powered
  • Laser-powered
  • Vibration-based
  • Other Technologies

Usabilities Covered:

  • Disposable Needle-free Injectors
  • Reusable Needle-free Injectors

Site of Deliveries Covered:

  • Subcutaneous Injectors
  • Intramuscular Injectors
  • Intra Dermal Injectors

Applications Covered:

  • Vaccine Delivery
  • Insulin Delivery
  • Oncology
  • Pain Management
  • Dermatology
  • Other Applications

End Users Covered:

  • Hospitals and Clinics
  • Home Care Settings
  • Research Laboratories
  • Pharmaceutical and Biotechnological Companies
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 Application Analysis
  • 3.9 End User Analysis
  • 3.10 Emerging Markets
  • 3.11 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Needle-Free Injection System Market, By Product

  • 5.1 Introduction
  • 5.2 Fillable Needle-free Injectors
  • 5.3 Prefilled Needle-free Injectors
  • 5.4 Other Products

6 Global Needle-Free Injection System Market, By Type

  • 6.1 Introduction
  • 6.2 Liquid-based Needle-free Injectors
  • 6.3 Projectile/Depot-based Needle-free Injectors
  • 6.4 Powder-based Needle-free Injectors
  • 6.5 Other Types

7 Global Needle-Free Injection System Market, By Technology

  • 7.1 Introduction
  • 7.2 Spring-based
  • 7.3 Gas-powered
  • 7.4 Laser-powered
  • 7.5 Vibration-based
  • 7.6 Other Technologies

8 Global Needle-Free Injection System Market, By Usability

  • 8.1 Introduction
  • 8.2 Disposable Needle-free Injectors
  • 8.3 Reusable Needle-free Injectors

9 Global Needle-Free Injection System Market, By Site of Delivery

  • 9.1 Introduction
  • 9.2 Subcutaneous Injectors
  • 9.3 Intramuscular Injectors
  • 9.4 Intra Dermal Injectors

10 Global Needle-Free Injection System Market, By Application

  • 10.1 Introduction
  • 10.2 Vaccine Delivery
  • 10.3 Insulin Delivery
  • 10.4 Oncology
  • 10.5 Pain Management
  • 10.6 Dermatology
  • 10.7 Other Applications

11 Global Needle-Free Injection System Market, By End User

  • 11.1 Introduction
  • 11.2 Hospitals and Clinics
  • 11.3 Home Care Settings
  • 11.4 Research Laboratories
  • 11.5 Pharmaceutical and Biotechnological Companies
  • 11.6 Other End Users

12 Global Needle-Free Injection System Market, By Geography

  • 12.1 Introduction
  • 12.2 North America
    • 12.2.1 US
    • 12.2.2 Canada
    • 12.2.3 Mexico
  • 12.3 Europe
    • 12.3.1 Germany
    • 12.3.2 UK
    • 12.3.3 Italy
    • 12.3.4 France
    • 12.3.5 Spain
    • 12.3.6 Rest of Europe
  • 12.4 Asia Pacific
    • 12.4.1 Japan
    • 12.4.2 China
    • 12.4.3 India
    • 12.4.4 Australia
    • 12.4.5 New Zealand
    • 12.4.6 South Korea
    • 12.4.7 Rest of Asia Pacific
  • 12.5 South America
    • 12.5.1 Argentina
    • 12.5.2 Brazil
    • 12.5.3 Chile
    • 12.5.4 Rest of South America
  • 12.6 Middle East & Africa
    • 12.6.1 Saudi Arabia
    • 12.6.2 UAE
    • 12.6.3 Qatar
    • 12.6.4 South Africa
    • 12.6.5 Rest of Middle East & Africa

13 Key Developments

  • 13.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 13.2 Acquisitions & Mergers
  • 13.3 New Product Launch
  • 13.4 Expansions
  • 13.5 Other Key Strategies

14 Company Profiling

  • 14.1 Ferring B.V
  • 14.2 INVIO Pharmaceutical Inc
  • 14.3 Bioject Medical Technologies
  • 14.4 Medical International Technology, Inc
  • 14.5 PharmaJet
  • 14.6 3M
  • 14.7 Portal Instruments
  • 14.8 NovaXS Biotech
  • 14.9 Enesi Pharma Limited
  • 14.10 Antares Pharma
  • 14.11 NuGen Medical Devices
  • 14.12 Crossject SA
  • 14.13 Injex Pharma AG

List of Tables

  • Table 1 Global Needle-Free Injection System Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Needle-Free Injection System Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Needle-Free Injection System Market Outlook, By Fillable Needle-free Injectors (2021-2030) ($MN)
  • Table 4 Global Needle-Free Injection System Market Outlook, By Prefilled Needle-free Injectors (2021-2030) ($MN)
  • Table 5 Global Needle-Free Injection System Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 6 Global Needle-Free Injection System Market Outlook, By Type (2021-2030) ($MN)
  • Table 7 Global Needle-Free Injection System Market Outlook, By Liquid-based Needle-free Injectors (2021-2030) ($MN)
  • Table 8 Global Needle-Free Injection System Market Outlook, By Projectile/Depot-based Needle-free Injectors (2021-2030) ($MN)
  • Table 9 Global Needle-Free Injection System Market Outlook, By Powder-based Needle-free Injectors (2021-2030) ($MN)
  • Table 10 Global Needle-Free Injection System Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 11 Global Needle-Free Injection System Market Outlook, By Technology (2021-2030) ($MN)
  • Table 12 Global Needle-Free Injection System Market Outlook, By Spring-based (2021-2030) ($MN)
  • Table 13 Global Needle-Free Injection System Market Outlook, By Gas-powered (2021-2030) ($MN)
  • Table 14 Global Needle-Free Injection System Market Outlook, By Laser-powered (2021-2030) ($MN)
  • Table 15 Global Needle-Free Injection System Market Outlook, By Vibration-based (2021-2030) ($MN)
  • Table 16 Global Needle-Free Injection System Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 17 Global Needle-Free Injection System Market Outlook, By Usability (2021-2030) ($MN)
  • Table 18 Global Needle-Free Injection System Market Outlook, By Disposable Needle-free Injectors (2021-2030) ($MN)
  • Table 19 Global Needle-Free Injection System Market Outlook, By Reusable Needle-free Injectors (2021-2030) ($MN)
  • Table 20 Global Needle-Free Injection System Market Outlook, By Site of Delivery (2021-2030) ($MN)
  • Table 21 Global Needle-Free Injection System Market Outlook, By Subcutaneous Injectors (2021-2030) ($MN)
  • Table 22 Global Needle-Free Injection System Market Outlook, By Intramuscular Injectors (2021-2030) ($MN)
  • Table 23 Global Needle-Free Injection System Market Outlook, By Intra Dermal Injectors (2021-2030) ($MN)
  • Table 24 Global Needle-Free Injection System Market Outlook, By Application (2021-2030) ($MN)
  • Table 25 Global Needle-Free Injection System Market Outlook, By Vaccine Delivery (2021-2030) ($MN)
  • Table 26 Global Needle-Free Injection System Market Outlook, By Insulin Delivery (2021-2030) ($MN)
  • Table 27 Global Needle-Free Injection System Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 28 Global Needle-Free Injection System Market Outlook, By Pain Management (2021-2030) ($MN)
  • Table 29 Global Needle-Free Injection System Market Outlook, By Dermatology (2021-2030) ($MN)
  • Table 30 Global Needle-Free Injection System Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 31 Global Needle-Free Injection System Market Outlook, By End User (2021-2030) ($MN)
  • Table 32 Global Needle-Free Injection System Market Outlook, By Hospitals and Clinics (2021-2030) ($MN)
  • Table 33 Global Needle-Free Injection System Market Outlook, By Home Care Settings (2021-2030) ($MN)
  • Table 34 Global Needle-Free Injection System Market Outlook, By Research Laboratories (2021-2030) ($MN)
  • Table 35 Global Needle-Free Injection System Market Outlook, By Pharmaceutical and Biotechnological Companies (2021-2030) ($MN)
  • Table 36 Global Needle-Free Injection System Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.